Axogen Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Axogen Inc trades at $49.66 (market cap $2.61B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.67. The key difference: Axogen Inc is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals.
| AXGN | VTIP | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | — |
52-Week High | $49.67 | $50.75 |
52-Week Low | $14.76 | $49.39 |
Enterprise Value | $2.52B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $49.67, up 3.01% with strong technical momentum. The stock shows bullish moving average signals despite recent earnings misses. Q2 2026 revenue grew 23.1% to $69.7M with raised full-year guidance to $279M, though net margins remain negative at -13.36%. Analyst consensus is strongly bullish with 16 buy ratings and $54.33 price target.
Growth prospects appear strong with expanding nerve care platform and reimbursement wins, but profitability challenges and high valuation multiples present risks. The stock trades near resistance at $50 with RSI indicating overbought conditions, suggesting potential near-term consolidation before further upside.
VTIP, the Vanguard Short-Term Inflation-Protected Securities ETF, trades at $49.66, showing minimal daily movement. Technical indicators are largely neutral, while the fund serves as a hedge against inflation, with recent news highlighting institutional accumulation and its role in income strategies amid persistent inflation above the Fed's target.
The outlook for VTIP is supported by its inflation-protection mandate in a higher inflation environment, offering a defensive income stream. Key risks include interest rate sensitivity and potential shifts in Federal Reserve policy that could impact short-term bond valuations.
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →